Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Respiratory syncytial virus
Recent news which mentions Respiratory syncytial virus
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
Tags
Science
Respiratory syncytial virus
Business News
From
CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Pharmaceuticals
Health & Science
Pfizer Inc
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Breaking news
Companies
Business
From
CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
Tags
Sanofi SA
Science
Business News
From
CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023
Tags
Social issues
Pfizer Inc
US: News
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
Breaking news
Companies
Health care industry
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
Respiratory syncytial virus
Business News
Shingles
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Immunizations
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
Health care industry
GSK plc
Business
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
US: News
Pfizer Inc
Pharmaceuticals
From
CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
June 21, 2023
Tags
Biotechnology
Biotech and Pharmaceuticals
Immunizations
From
CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
Tags
GSK plc
Business
Pandemics
From
CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
May 22, 2023
Tags
Health care industry
Business
Moderna Inc
From
CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
May 18, 2023
Tags
Companies
Health care industry
GSK plc
From
CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023
Tags
US: News
Pfizer Inc
Health & Science
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
GSK plc
Companies
Respiratory syncytial virus
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
Disease outbreaks
Policy
Health & Science
From
CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
Tags
Respiratory syncytial virus
Technology
Moderna Inc
From
CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
December 26, 2022
Tickers
LIFE
Tags
Life
Flu
Hospitality and leisure industry
From
CNBC.com News
Why flu season is so bad this year
November 10, 2022
Tickers
LIFE
Tags
Biotech and Pharmaceuticals
Science
Respiratory syncytial virus
From
CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
November 01, 2022
Tags
US Top News and Analysis
Politics
U/S/ Economy
From
CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
May 11, 2022
Tickers
AZN
AZNCF
SNY
Tags
Health Care
REspiratory syncytial virus
Large Cap
From
Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
March 24, 2022
Tickers
PFE
Tags
Health Care
General
Biotech
From
Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
December 07, 2021
Tickers
JNJ
Tags
Biotech
REspiratory syncytial virus
News
From
Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
October 04, 2021
Tickers
JNJ
Tags
Benzinga
Phase 2 Trial
JNJ
From
Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
September 02, 2021
Tickers
PFE
Tags
Health Care
General
Phase 3 Trial
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright